Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lode

Showing results (181-190 of 369) with videos related to

Pageof 37
Sort By:
The Journal of Antimicrobial Chemotherapy|June 1, 1996
Azithromycin--review of key chemical, pharmacokinetic and microbiological featuresH Lode, K Borner, P Koeppe, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1995
Lower respiratory tract infections in the intensive care unit: consequences of antibiotic resistance for choice of antibioticH Lode, T Schaberg, M Raffenberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1993
Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosisJ Günther, H Lode, M Raffenberg, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 1975
[Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)]H Lode, B Kemmerich, P Koeppe, et al.
European Journal of Clinical Microbiology|February 1, 1983
Determination of cefmenoxime in human body fluids by high-performance liquid chromatographyK Borner, E Borner, H Lode, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1972
[Lung function studies in young apparently health cigarette smokers versus non-smokers]U Hüttemann, P Oswald, H Lode, et al.
Clinical Pharmacokinetics|January 1, 1989
Unique aspects of quinolone pharmacokineticsH Lode, G Höffken, K Borner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumoniaH. Lode, M. Aubier, H. Portier, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1984
Comparative pharmacokinetics of apalcillin and piperacillinH Lode, A Elvers, P Koeppe, et al.
Deutsche Medizinische Wochenschrift (1946)|May 12, 1995
[Diagnosis of sarcoidosis]N Schönfeld, T Schaberg, H Lode, et al.
Pageof 37

Showing results (181-190 of 369) with videos related to

Sort By:
Pageof 37
The Journal of Antimicrobial Chemotherapy|June 1, 1996
Azithromycin--review of key chemical, pharmacokinetic and microbiological featuresH Lode, K Borner, P Koeppe, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1995
Lower respiratory tract infections in the intensive care unit: consequences of antibiotic resistance for choice of antibioticH Lode, T Schaberg, M Raffenberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1993
Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosisJ Günther, H Lode, M Raffenberg, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 1975
[Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)]H Lode, B Kemmerich, P Koeppe, et al.
European Journal of Clinical Microbiology|February 1, 1983
Determination of cefmenoxime in human body fluids by high-performance liquid chromatographyK Borner, E Borner, H Lode, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1972
[Lung function studies in young apparently health cigarette smokers versus non-smokers]U Hüttemann, P Oswald, H Lode, et al.
Clinical Pharmacokinetics|January 1, 1989
Unique aspects of quinolone pharmacokineticsH Lode, G Höffken, K Borner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumoniaH. Lode, M. Aubier, H. Portier, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1984
Comparative pharmacokinetics of apalcillin and piperacillinH Lode, A Elvers, P Koeppe, et al.
Deutsche Medizinische Wochenschrift (1946)|May 12, 1995
[Diagnosis of sarcoidosis]N Schönfeld, T Schaberg, H Lode, et al.
Pageof 37